Free Trial

Vera Therapeutics (VERA) Competitors

Vera Therapeutics logo
$23.00 +0.03 (+0.13%)
Closing price 04:00 PM Eastern
Extended Trading
$23.00 0.00 (0.00%)
As of 06:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VERA vs. TGTX, LNTH, NUVL, TLX, AXSM, ADMA, AKRO, PCVX, RYTM, and KRYS

Should you be buying Vera Therapeutics stock or one of its competitors? The main competitors of Vera Therapeutics include TG Therapeutics (TGTX), Lantheus (LNTH), Nuvalent (NUVL), Telix Pharmaceuticals (TLX), Axsome Therapeutics (AXSM), ADMA Biologics (ADMA), Akero Therapeutics (AKRO), Vaxcyte (PCVX), Rhythm Pharmaceuticals (RYTM), and Krystal Biotech (KRYS). These companies are all part of the "pharmaceutical products" industry.

Vera Therapeutics vs. Its Competitors

TG Therapeutics (NASDAQ:TGTX) and Vera Therapeutics (NASDAQ:VERA) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, media sentiment, valuation and analyst recommendations.

TG Therapeutics has higher revenue and earnings than Vera Therapeutics. Vera Therapeutics is trading at a lower price-to-earnings ratio than TG Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TG Therapeutics$329M17.18$23.38M$0.24148.38
Vera TherapeuticsN/AN/A-$152.15M-$3.00-7.67

TG Therapeutics has a net margin of 10.13% compared to Vera Therapeutics' net margin of 0.00%. TG Therapeutics' return on equity of 18.88% beat Vera Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
TG Therapeutics10.13% 18.88% 7.05%
Vera Therapeutics N/A -40.59%-34.54%

TG Therapeutics currently has a consensus price target of $40.80, indicating a potential upside of 14.57%. Vera Therapeutics has a consensus price target of $65.00, indicating a potential upside of 182.61%. Given Vera Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Vera Therapeutics is more favorable than TG Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TG Therapeutics
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
Vera Therapeutics
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
2 Strong Buy rating(s)
3.10

58.6% of TG Therapeutics shares are owned by institutional investors. Comparatively, 99.2% of Vera Therapeutics shares are owned by institutional investors. 10.6% of TG Therapeutics shares are owned by insiders. Comparatively, 16.3% of Vera Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, TG Therapeutics had 6 more articles in the media than Vera Therapeutics. MarketBeat recorded 8 mentions for TG Therapeutics and 2 mentions for Vera Therapeutics. TG Therapeutics' average media sentiment score of 1.17 beat Vera Therapeutics' score of 0.56 indicating that TG Therapeutics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TG Therapeutics
5 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Vera Therapeutics
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

TG Therapeutics has a beta of 1.91, meaning that its stock price is 91% more volatile than the S&P 500. Comparatively, Vera Therapeutics has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500.

Summary

TG Therapeutics beats Vera Therapeutics on 10 of the 16 factors compared between the two stocks.

Get Vera Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for VERA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VERA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VERA vs. The Competition

MetricVera TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.47B$2.88B$5.46B$8.92B
Dividend YieldN/A2.44%5.24%4.04%
P/E Ratio-7.6720.8027.0120.12
Price / SalesN/A193.35380.1493.35
Price / CashN/A41.7026.2128.59
Price / Book2.537.487.995.57
Net Income-$152.15M-$55.04M$3.16B$248.40M
7 Day PerformanceN/A5.44%3.69%6.04%
1 Month Performance1.32%2.38%2.91%7.69%
1 Year Performance-36.08%5.53%34.30%20.97%

Vera Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VERA
Vera Therapeutics
3.3236 of 5 stars
$23.00
+0.1%
$65.00
+182.6%
-35.5%$1.47BN/A-7.6740
TGTX
TG Therapeutics
3.9016 of 5 stars
$35.99
-2.0%
$40.80
+13.4%
+89.3%$5.71B$386.39M149.96290News Coverage
Positive News
LNTH
Lantheus
4.4243 of 5 stars
$81.86
+0.5%
$130.50
+59.4%
+0.4%$5.66B$1.53B23.26700
NUVL
Nuvalent
3.8546 of 5 stars
$76.30
-4.2%
$119.60
+56.7%
+6.9%$5.48BN/A-17.3840
TLX
Telix Pharmaceuticals
N/A$16.07
+0.4%
$22.00
+36.9%
N/A$5.44B$516.72M0.00N/A
AXSM
Axsome Therapeutics
4.73 of 5 stars
$104.39
+1.0%
$172.33
+65.1%
+31.1%$5.14B$432.16M-18.09380
ADMA
ADMA Biologics
4.1398 of 5 stars
$18.21
+0.3%
$27.67
+51.9%
+56.0%$4.35B$426.45M21.42530Positive News
AKRO
Akero Therapeutics
3.444 of 5 stars
$53.36
-5.0%
$82.50
+54.6%
+140.2%$4.25BN/A-27.3630
PCVX
Vaxcyte
1.5968 of 5 stars
$32.51
-0.2%
$136.50
+319.9%
-58.9%$4.19BN/A-8.15160
RYTM
Rhythm Pharmaceuticals
3.4405 of 5 stars
$63.19
+0.7%
$77.31
+22.3%
+57.0%$4.02B$136.86M-22.49140News Coverage
Analyst Forecast
KRYS
Krystal Biotech
4.491 of 5 stars
$137.46
-1.0%
$211.13
+53.6%
-24.2%$3.97B$333.45M33.04210

Related Companies and Tools


This page (NASDAQ:VERA) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners